Sue Dunkerton, HealthTech and Medicines KTN
11 December 2012

The HealthTech and Medicines KTN (Health KTN) supports business innovations through partnerships, access to funding and knowledge transfer
Connecting Partners
• Bringing together & facilitating collaborations with a common goal
Access to Funding
• Identify and influence new and existing sources of funding
Knowledge Transfer
• Opening doors to wider networks of people/organisations

Clinical Needs
High Value
Manufacturing
Detection and
Identification of
Infectious Agents
Emerging
Medical
Technologies
Regenerative
Medicine
Assisted Living
Novel
Therapies
Synthetic
Biology
Stratified Medicine

Finance For Innovation
Technology Readiness Level for Finance for
Innovation in the UK and Europe.
TSB National- SBRI, KTP,
Biomedical Catalyst
Devolved Administration/Regional
Funding- Manufacturing Advisor
Service (MAS)
Research Councils- Managed programmes,
IKC’s
Devolved Administration/ Regional Funding-
Regional Growth Funds, Smart: Scotland
Europe- AAL
DH/NIHR- i4i
TSB National & MRC- Biomedical Catalyst
Research Councils- Case Awards, Industrial
Case Awards, CDTs
Europe- Networks of Excellence
Research Councils- Responsive Mode Research,
KTA
5
4
3
2
7
6
9
8
1
Businesses
Business Angels
Venture Capitalists
Private Investors
TSB National- Grant for R&D, Biomedical Catalyst ,
SMART, Innovation Vouchers
Europe-PPP’s, Research for SMEs, Eureka/Eurostars
Devolved Administration/Regional Funding- R&D
Grant Scotland, Welsh Government
TSB National-Innovation Platforms, Collaborative R&D,
Catapults, Biomedical Catalyst
Europe- Framework 7 cooperation Health/NMP/ICT,
Research For SMEs, AAL
DoH/NIHR- Health Innovation Challenge Fund
Useful websites for more information:
• Technology Strategy Board (TSB) National www.innovateuk.org
• Europe www.fp7uk.co.uk
• Devolved Administration- www.scottish-enterprise.com, www.bis.gov.uk/RGF , http://wales.gov.uk/funding
• DH/NIHR www.nihr.ac.uk
• Research Councils www.rcuk.ac.uk

• The Technology Strategy Board is to invest up to £10m in fasttrack and collaborative research and development projects that stimulate innovation across the key enabling technology areas of advanced materials, biosciences, electronics, sensors and photonics and information and communications technology
• Competition is now open and deadline for registering express of interest is 23 rd January 2013

• i4i Product Development Award – 100% funding, England and Wales only
• i4i Challenge Award – 100% funding, lead applicant must be in
England
• Health Innovation Challenge Fund – 2 themed calls a year (UK wide, with Wellcome Trust)
• Healthcare Technology Cooperatives - Provide an excellent route into the NHS for selected areas of unmet need 2 pilots, 6-8 launching
2013 (based in English Trust, open to national and international businesses)

• Devolved Administrations :
Welsh Assembly Government (WAG)
– £100m Welsh Life Sciences Fund
Scotland
– SMART: SCOTLAND
– Research and Development Grant
– Proof of Concept Fund
• Eurostars – Supports UK SMEs
• EU Framework Programme FP7 – Topics: Health, NMP, ICT, IMI (JTI)
• Horizon 2020
• Ambient Assisted Living

• UKTI
– Passport to Export
– Export Marketing Research Scheme
– Overseas Market Introduction
Service
– Gateway to Global Growth
– UKTI Venture Capital Team
•
Fiscal Measure
R&D tax credit for SMEs
– increased the level of superdeduction relief available to 225%
– no minimum spend requirement
•
• £300m Enterprise Capital Funds
(ECF) programme
UK Innovation Investment Fund
• Patent Box
– 10% rate of corporation tax on profits from patents/IP
– applies worldwide to existing and new IP
— UK Future Technologies Fund (UKFTF) • 24% Corporate Tax Rate
• £50m Business Angel coinvestment Fund

Accessing
Networks
Accessing
Research
Capabilities
Accessing
Clinical Needs
Accessing
Market
Information
Accessing
Business
Support
Innovation
Support Map
Selling to the
NHS
Complying with
Regulations
Accessing
Funding